Investment Q&A

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Your comments on their last quarter results. Thanks .... Cal

Upvote 1

Read Answer Asked by cal on November 25, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX
• Intuitive Surgical Inc. (ISRG $518.62)
  • $518.62 Fwd P/E: 75.93X Cap: $185.88B
  • View ISRG Profile
  • View Questions on ISRG
• Church & Dwight Company Inc. (CHD $96.60)
  • $96.60 Fwd P/E: 41.46X Cap: $23.79B
  • View CHD Profile
  • View Questions on CHD
• Eli Lilly and Company (LLY $771.71)
  • $771.71 Fwd P/E: 62.79X Cap: $731.37B
  • View LLY Profile
  • View Questions on LLY
• Martin Marietta Materials Inc. (MLM $565.03)
  • $565.03 Fwd P/E: 32.4X Cap: $32.93B
  • View MLM Profile
  • View Questions on MLM
• Philip Morris International Inc (PM $178.73)
  • $178.73 Fwd P/E: 36.78X Cap: $278.19B
  • View PM Profile
  • View Questions on PM
• Dollarama Inc. (DOL $187.74)
  • $187.74 Fwd P/E: 42.86X Cap: $52.04B
  • View DOL Profile
  • View Questions on DOL
• CCL Industries Inc. Unlimited Class B Non-Voting Shares (CCL.B $79.97)
  • $79.97 Fwd P/E: 16.56X Cap: $14.13B
  • View CCL.B Profile
  • View Questions on CCL.B
  • View Reports on CCL.B
• North West Company Inc. (The) (NWC $47.65)
  • $47.65 Fwd P/E: 16.9X Cap: $2.27B
  • View NWC Profile
  • View Questions on NWC
  • View Reports on NWC
• Agnico Eagle Mines Limited (AEM $161.61)
  • $161.61 Fwd P/E: 25.1X Cap: $81.24B
  • View AEM Profile
  • View Questions on AEM
• Premium Brands Holdings Corporation (PBH $90.51)
  • $90.51 Fwd P/E: 34.28X Cap: $4.06B
  • View PBH Profile
  • View Questions on PBH
  • View Reports on PBH
• Capstone Copper Corp. (CS $7.74)
  • $7.74 Fwd P/E: 51.84X Cap: $5.89B
  • View CS Profile
  • View Questions on CS
• Novo Nordisk A/S (NVO $64.31)
  • $64.31 Fwd P/E: 18.14X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO
• Vitalhub Corp. (VHI $12.26)
  • $12.26 Fwd P/E: 272.44X Cap: $683M
  • View VHI Profile
  • View Questions on VHI
  • View Reports on VHI
• WELL Health Technologies Corp. (WELL $4.65)
  • $4.65 Cap: $1.15B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL
• Linde plc (LIN $465.01)
  • $465.01 Fwd P/E: 33.77X Cap: $219.15B
  • View LIN Profile
  • View Questions on LIN
• United States Lime & Minerals Inc. (USLM $104.79)
  • $104.79 Fwd P/E: 24.95X Cap: $3B
  • View USLM Profile
  • View Questions on USLM
• British American Tobacco p.l.c. (BTI $51.59)
  • $51.59 Cap: $112.18B
  • View BTI Profile
  • View Questions on BTI

Q: Hello

What is 5is shortlist preferences for these 3 sectors: Materials, Consumer Defensive & Healthcare.
* 3 USA & 3 CDA choices per would be a great starting point

Upvote 27

Read Answer Asked by Brant on November 14, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: I have a small position in this company and a long term time horizon.
Looks to me like a good candidate to either go private or be bought out.
Am I way off the mark on this.?
Thanks John

Upvote 1

Read Answer Asked by John on June 28, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Your comments on their last quarter results please.

Good growth, clean balance sheet, new products coming on stream, efficient capital allocator. Seems like a 5i type of investment. Would you consider it for one of your model portfolios?

Upvote 1

Read Answer Asked by Adam on June 03, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Would like your review of results. Do you think this is a good entry point for a 5 year hold and what return can I reasonably expect over 5 years, Thanks John

Upvote 2

Read Answer Asked by John on March 15, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: would like your view on rx, last i could find was may 2023.
thank you

Upvote 2

Read Answer Asked by howard on January 16, 2024

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: On May 23 I asked for 5iR thoughts on RX recent quarter. I see that RX does not report until May 26. So would you please hold off my request until they report. Thanks ... Cal

Upvote 0

Read Answer Asked by cal on May 29, 2023

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX
• Inventronics Limited (IVX $0.70)
  • $0.70 Fwd P/E: 23.33X Cap: $3M
  • View IVX Profile
  • View Questions on IVX
• Atlas Engineered Products Ltd. (AEP $0.89)
  • $0.89 Cap: $62M
  • View AEP Profile
  • View Questions on AEP
• kneat.com inc. (KSI $5.80)
  • $5.80 Cap: $544M
  • View KSI Profile
  • View Questions on KSI
  • View Reports on KSI
• Jemtec Inc. (JTC $0.90)
  • $0.90 Fwd P/E: 22.5X Cap: $2M
  • View JTC Profile
  • View Questions on JTC

Q: Can you give me your 5 best microcaps in either the US or Canada that are cash rich, undervalued, that could possibly do very well when the market recovers?
Thx

Upvote 0

Read Answer Asked by Adam on December 29, 2022

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: In a recent question concerning RX, in your answer you wrote due to its size we would exercise some caution around position sizing. What sizing percentage would you suggest. Thanks … Cal

Upvote 0

Read Answer Asked by cal on November 04, 2022

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: In your comments on Biosyent Oct /21 , you indicated that , while very small , the company had impressive financials . Could I have your up-dated assessment post recent earnings and in particular in light of its announcement of an inaugural dividend by the end of this year.

Upvote 0

Read Answer Asked by William on September 13, 2022

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX
• Twilio Inc. Class A (TWLO $131.00)
  • $131.00 Cap: $20.07B
  • View TWLO Profile
  • View Questions on TWLO
• Viemed Healthcare Inc. (VMD $6.49)
  • $6.49 Fwd P/E: 21.63X Cap: $256M
  • View VMD Profile
  • View Questions on VMD
• Nuvei Corporation (NVEI)
  • Cap: $4.81B
  • View NVEI Profile
  • View Questions on NVEI
• Volkswagen AG ADR (VWAGY $10.60)
  • $10.60 Fwd P/E: 0.28X Cap: $2.08B
  • View VWAGY Profile
  • View Questions on VWAGY

Q: Thoughts on the above stocks, buy, sell or hold?

Upvote 0

Read Answer Asked by Colin I on January 03, 2022

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: What is your thoughts on this small cap pharmaceutical company and future earnings growth…

Upvote 0

Read Answer Asked by Sonny on October 22, 2021

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: I have not seen a question relating to Biosent since July. I took a small position back then and was considering adding to it. Your thoughts on the last earnings reports and prospects for this company going forward.

Upvote 0

Read Answer Asked by Ric on December 28, 2020

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Any information on why the stock is moving higher today?
Thank you

Upvote 0

Read Answer Asked by Eric on July 20, 2020

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Please comment on the most recent results. Thanks.

Upvote 0

Read Answer Asked by Murray on June 02, 2020

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: What would you do with RX after recent results?
Thanks for helping during these difficult times.

Upvote 0

Read Answer Asked by Judith on March 27, 2020

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX
• HLS Therapeutics Inc. (HLS $4.90)
  • $4.90 Cap: $155M
  • View HLS Profile
  • View Questions on HLS

Q: your thoughts on recent Q3 results. worth sticking with this company or can you suggest alternative investment.
thanks
Don

Upvote 0

Read Answer Asked by Don on November 21, 2019

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: I would like your opinion on the company. They seem to have a a fair bit of cash and no debt and would like your opinion if this might be a "speculative" stock to invest in.

Upvote 0

Read Answer Asked by Colleen on April 05, 2019

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Any idea why the big drop in Biosyent this week. Also thoughts on their Q3 results
Thanks
Don

Upvote 0

Read Answer Asked by Don on November 21, 2018

• BioSyent Inc. (RX $11.45)
  • $11.45 Fwd P/E: 17.09X Cap: $128M
  • View RX Profile
  • View Questions on RX

Q: Can you comment on q1 results just released please. What do you think of the stock? Thanks again.

Upvote 0

Read Answer Asked by Scott on May 30, 2018